The latest London South East Webinar takes place on July 6. Come and hear CEO’s from Orosur Mining, Caledonia Mining, Glantus Holdings and Tekcapital speak. Please register here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Inv Share News (BRH)

Share Price Information for Braveheart Inv (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 43.00
Bid: 42.00
Ask: 44.00
Change: -2.00 (-4.44%)
Spread: 2.00 (4.76%)
Open: 45.00
High: 45.00
Low: 43.00
Yest. Close: 45.00
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

IN BRIEF: Paraytec clinical sample pipeline operational - Braveheart

Mon, 1st Mar 2021 13:54

Braveheart Investment Group PLC - AIM-listed investment company with six strategic investments - Provides update on Paraytec Ltd and University of Sheffield's progress in developing Covid-19 test. Says testing first 500 samples from Sheffield Hospitals Trust a "key focus" for Paraytec team in last month, with average time to acquire test result a "market-leading value" at less than 120 seconds. Notes clinical pipeline now "fully functional".

Braveheart owns 100% of Paraytec, which has adopted an additional comparator test development by the university to verify the presence of intact virus particles, which makes it different from other tests for viral RNS levels. These other tests are more likely to cause a patient to test positive when no longer infectious.

Additionally, Paraytec is using isolated lab-grown virus to improve sensitivity of its instrument for detecting pre-symptomatic and early-stage symptomatic virus levels. It expects to confirms a lower limit of detection of 1,000 virons per millilitre of sample, another market-leading value.

The high speed and high sensitivity might allow for multiplexed "matrix" testing, combining samples from multiple people for simultaneous analysis. For example, 20 parallel tests would yield individual results for as many as a hundred people. This kind of test would be useful for large events.

Paraytec now progressing to prospective clinical validation with a larger number of patient samples and will seek a CE mark for its test. This trail is expected to take two months.

Current stock price: 71.90 pence; down 28% on Monday

Year-to-date change: up sharply from 28p on December 31

By Anna Farley; annafarley@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News

TRADING UPDATES: DP Poland sales improve; Braveheart swings to profit

TRADING UPDATES: DP Poland sales improve; Braveheart swings to profit

18 Jun 21 13:23

EXECUTIVE CHANGES: Lloyds Banking appoints BT Digital Officer to board

EXECUTIVE CHANGES: Lloyds Banking appoints BT Digital Officer to board

16 Jun 21 17:10

TRADING UPDATES: Motif Bio takeover called off; Yamana buys at Wasamac

TRADING UPDATES: Motif Bio takeover called off; Yamana buys at Wasamac

14 Jun 21 20:33

Remote Monitored Systems shares plummet amid widened annual loss

Remote Monitored Systems shares plummet amid widened annual loss

9 Jun 21 10:14

EXECUTIVE CHANGES: Long-serving Cranswick chair Davey to step down

EXECUTIVE CHANGES: Long-serving Cranswick chair Davey to step down

18 May 21 17:01

IN BRIEF: Braveheart CEO Brown cuts stake to 5% with GBP827,000 sale

IN BRIEF: Braveheart CEO Brown cuts stake to 5% with GBP827,000 sale

6 May 21 15:06

AIM WINNERS & LOSERS: Zambeef Products rises 16% on positive outlook

AIM WINNERS & LOSERS: Zambeef Products rises 16% on positive outlook

6 May 21 11:39

TRADING UPDATES: Supreme annual revenue jumps; Pelatro in Asia deal

TRADING UPDATES: Supreme annual revenue jumps; Pelatro in Asia deal

4 May 21 19:13

AIM WINNERS & LOSERS: Kodal Minerals up on Bougouni licence progress

AIM WINNERS & LOSERS: Kodal Minerals up on Bougouni licence progress

4 May 21 11:36

DIRECTOR DEALINGS: Marshalls CEO's Spouse sells GBP1.1 million worth

DIRECTOR DEALINGS: Marshalls CEO's Spouse sells GBP1.1 million worth

15 Apr 21 21:43

IN BRIEF: Braveheart Investment Director Hallam sells shares

IN BRIEF: Braveheart Investment Director Hallam sells shares

9 Apr 21 17:26

DIRECTOR DEALINGS: Braveheart CEO sells; AJ Bell finance chief buys

DIRECTOR DEALINGS: Braveheart CEO sells; AJ Bell finance chief buys

1 Apr 21 13:46

AIM WINNERS & LOSERS: Oilex hails milestone with Cambay resolution

AIM WINNERS & LOSERS: Oilex hails milestone with Cambay resolution

1 Apr 21 10:34

EXECUTIVE CHANGES: F&C Investment Trust hires CBI chief economist

EXECUTIVE CHANGES: F&C Investment Trust hires CBI chief economist

29 Mar 21 15:13

TRADING UPDATES: Contango in offtake talks for coking coal in Zimbabwe

TRADING UPDATES: Contango in offtake talks for coking coal in Zimbabwe

26 Mar 21 15:40

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.